Otsuka Pharmaceutical Development & Commercialization, Inc.

This was a long-term study to check the safety and see if a drug called AVP-786 could continue to help control agitation in people with Alzheimer's disease. The study involved nearly 1,200 participants who had already been in related shorter trials. The main goal was to monitor s…